|
Press Releases |
|
 |
|
Friday, September 9, 2022 |
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
Tuesday, July 19, 2022 |
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
Thursday, February 17, 2022 |
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
Wednesday, February 16, 2022 |
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries |
Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company continues to scale up the manufacturing and distribution of its COVID-19 vaccine and future mRNA vaccines and therapeutics. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
MyFintech Week 2025 Highlights Transformative Forces in Finance
Aug 8, 2025 11:06 HKT/SGT
|
|
|
DAESHIN MC Targets Singapore Market with Smart Cleaning Solutions at 'BEX ASIA 2025'
Aug 8, 2025 11:00: JST
|
|
|
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million
Aug 8, 2025 10:08 HKT/SGT
|
|
|
DAESHIN MC Targets Singapore Market with Smart Cleaning Solutions at 'BEX ASIA 2025'
Aug 8, 2025 10:00 HKT/SGT
|
|
|
消費場景持續豐富 鍋圈計劃五年內達成第二個萬店目標
Aug 8, 2025 09:56 HKT/SGT
|
|
|
From Food Culture to Future Living: Shiology Makes Splash at HK Book Fair
Aug 8, 2025 09:00 HKT/SGT
|
|
|
HKTDC to release report on Hong Kong Businesses Navigating Mainland China E-commerce Retail Market - Consumer Survey Results
Aug 8, 2025 08:19 HKT/SGT
|
|
|
University of Cyberjaya Welcomes Education Reforms under RMK13: A Bold Step Toward Future-Ready Talent and Inclusive Innovation
Aug 8, 2025 00:09 HKT/SGT
|
|
|
Graid Technology Announces Global Availability of SupremeRAID(TM) HE (HPC Edition), Wins Best of Show at FMS 2025
Aug 7, 2025 21:45 HKT/SGT
|
|
|
U.S. Polo Assn. Named No. 1 Sports Licensor and Top 25 on License Global' Prestigious 'Top Global Licensors' List
Aug 7, 2025 19:00 HKT/SGT
|
|
|
U.S. Polo Assn. 被評為全球第一體育授權商,並榮登《License Global》權威榜單「全球頂級授權商」前 25 名
Aug 7, 2025 19:00 HKT/SGT
|
|
|
U.S. Polo Assn. 被评为全球第一体育授权商,并荣登《License Global》权威榜单“全球顶级授权商”前 25 名
Aug 7, 2025 19:00 HKT/SGT
|
|
|
極智嘉業績加速兌現 具身智能打開高增長曲線!獲摩根士丹利、德意志銀行等知名機構首次覆蓋並看好
Aug 7, 2025 18:19 HKT/SGT
|
|
|
极智嘉业绩加速兑现 具身智能打开高增长曲线!获摩根士丹利、德意志银行等知名机构首次覆盖并看好
Aug 7, 2025 18:19 HKT/SGT
|
|
|
Team Mitsubishi Ralliart Conducts Shakedown Ahead of Asia Cross Country Rally 2025: Targeting First Overall Championship in Three Years
Aug 7, 2025 18:40 JST
|
|
|
|
More News >> |
|
|
|
|
|